SynthesisIn vivo (Athens, Greece)

First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.

Wolfram Malter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.